I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
High-dose cytarabine monotherapy is superior to standard-do..:
Xiaoyu Wang
;
Dan Liu
;
Erling Chen
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1070588/full. , 2023
Link:
https://doi.org/10.3389/fonc.2022.1070588
RT Journal T1
High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:75ee0e0a3e4e4194bc8ab665961c910b&Exemplar=1&LAN=DE A1 Xiaoyu Wang A1 Dan Liu A1 Erling Chen A1 Li Wang A1 Na Zhao A1 Li Zhou A1 Juan Tong A1 Lei Xue A1 Lei Zhang A1 Liangquan Geng A1 Baolin Tang A1 Huilan Liu A1 Xin Liu A1 Changcheng Zheng PB Frontiers Media S.A. YR 2023 K1 acute myeloid leukemia K1 2022 European Leukemia Net K1 high-dose cytarabine K1 multiagent sequential chemotherapy K1 consolidation K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.1070588/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.1070588 DO https://doi.org/10.3389/fonc.2022.1070588 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)